
BeyondSpring BYSI
€ 1.14
-0.74%
Quartalsbericht 2025-Q3
hinzugefügt 21.02.2026
BeyondSpring ROA 2011-2026 | BYSI
ROA Jährlich BeyondSpring
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.41 | -84.75 | -72.0 | -78.6 | -52.1 | -85.48 | -776.85 | -279.53 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -32.41 | -776.85 | -182.72 |
ROA Vierteljährlich BeyondSpring
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.89 | -2.66 | 3.15 | - | - | - | - | - | -18.67 | -37.35 | -60.74 | -59.57 | -96.47 | -114.71 | -118.61 | -112.21 | -139.65 | -130.18 | -225.13 | -242.65 | -242.65 | -262.93 | -188.41 | -152.6 | -140.53 | -176.18 | -154.56 | -146.45 | -146.45 | -110.8 | -84.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.15 | -262.93 | -121.91 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
-123.72 | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
AIkido Pharma
AIKI
|
-31.2 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
-48.74 | $ 2.12 | -12.96 % | $ 218 M | ||
|
Allena Pharmaceuticals
ALNA
|
-140.01 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
-101.11 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | ||
|
Aptose Biosciences
APTO
|
-251.11 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
Athira Pharma
ATHA
|
-164.92 | - | - | $ 269 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-206.68 | - | 17.91 % | $ 11.1 M | ||
|
Altimmune
ALT
|
-68.24 | $ 4.24 | -1.62 % | $ 301 M | ||
|
Arena Pharmaceuticals
ARNA
|
-78.56 | - | -6.81 % | $ 3.04 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Avenue Therapeutics
ATXI
|
-437.72 | - | -52.27 % | $ 4.45 M | ||
|
Athersys
ATHX
|
-144.48 | - | 3.77 % | $ 22.4 M | ||
|
Axcella Health
AXLA
|
-428.94 | - | -16.42 % | $ 249 M | ||
|
AstraZeneca PLC
AZN
|
0.11 | - | - | $ 96.9 B | ||
|
AVEO Pharmaceuticals
AVEO
|
-50.64 | - | - | $ 521 M | ||
|
Atreca
BCEL
|
-62.67 | - | -11.76 % | $ 5.79 M | ||
|
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | ||
|
Agenus
AGEN
|
-82.01 | $ 3.34 | 0.15 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
-31.82 | $ 28.71 | -5.03 % | $ 1.66 B | ||
|
bluebird bio
BLUE
|
-34.23 | - | - | $ 546 M | ||
|
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
2.66 | - | - | - | ||
|
Фармсинтез
LIFE
|
-25.57 | - | - | - |